EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for VIVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -0.2554
March 31, 2026 -2.208
December 31, 2025 -1.032
September 30, 2025 -0.977
June 30, 2025 -1.136
March 31, 2025 3.61
December 31, 2024 -2.291
September 30, 2024 -0.1416
June 30, 2024 -0.228
March 31, 2024 -0.3021
December 31, 2023 -0.3954
September 30, 2023 -0.4581
June 30, 2023 -0.4621
March 31, 2023 -0.8557
December 31, 2022 -0.3746
September 30, 2022 -0.3812
June 30, 2022 -0.3691
March 31, 2022 -0.2194
December 31, 2021 -0.402
September 30, 2021 -0.4026
June 30, 2021 -0.2912
March 31, 2021 -0.2994
December 31, 2020 -0.3661
September 30, 2020 -1.363
June 30, 2020 -0.424
Date Value
March 31, 2020 -0.4172
December 31, 2019 -0.5166
September 30, 2019 -0.9656
June 30, 2019 -0.9968
March 31, 2019 -1.169
December 31, 2018 -1.101
September 30, 2018 -1.024
June 30, 2018 -1.40
March 31, 2018 -1.40
December 31, 2017 -1.40
September 30, 2017 -1.80
June 30, 2017 -24.00
March 31, 2017 -2.00
December 31, 2016 -1.80
September 30, 2016 -2.00
June 30, 2016 -1.80
March 31, 2016 -1.80
December 31, 2015 -2.20
September 30, 2015 -2.40
June 30, 2015 -2.00
March 31, 2015 -1.913
December 31, 2014 -1.80
September 30, 2014 -2.20
June 30, 2014 -1.60
March 31, 2014 -1.660

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
Anika Therapeutics, Inc. 0.2412
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412